

Cover Story
The caveats should be acknowledged: Yes, all cancer centers are different. If you've seen one, you've seen one. Yes, every center director has a different political and economic situation on his or her hands, and, sure, the observation that follows in the next paragraph could well be a fluke:
By Matthew Bin Han Ong
In Brief


Trending Stories
- Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pam Bondi diagnosed with thyroid cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Wafik El-Deiry steps down as director of Brown’s Legorreta Cancer Center
















